Cloudiness, particles, clumping, aggregation, or precipitation may be caused by peptide/diluent incompatibility
After all, this would theoretically activate three distinct receptor systems: amylin, GIP, and GLP-1
L.-C.DoN
The GIP receptor activation in both tirzepatide and retatrutide appears to contribute substantially to insulin sensitization in fat tissue, which may explain why both outperform semaglutide on this metric
Because this area has a rich blood supply but is less vascular than muscle, allowing for a slower, more sustained release and absorption of the peptide into the systemic circulation
However, left untreated, it may cause symptoms like: Weakness, tiredness, or lightheadedness